Aceso Life Science Group Limited
0474.HK
Get informed when a big investor buys or sells
+ FollowMarket Cap$1.28B
Close$
Share Statistics
| Market cap | $1.28 Billion |
|---|---|
| Enterprise Value | $2.32 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.06 |
| Beta | -0.36 |
| Outstanding Shares | 8,888,889,000 |
Return
| Return on Equity | -121.88% |
|---|---|
| Return on Assets | -31.15% |
| Return on Invested Capital | -57.51% |
Valuation & Multiples
| P/E Ratio | 3.04 |
|---|---|
| PEG | -3.25 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 8.96 |
| Enterprise Value to EBIT | -2.34 |
| Enterprise Value to Net Income | -5 |
| Total Debt to Enterprise | 0.51 |
| Debt to Equity | 2.6 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Aceso Life Science Group Limited
28 employees
CEO: Shen Hui Aceso Life Science Group Limited, an investment holding company, engages in the financial services, property leasing and development, and construction machinery businesses in Hong Kong and the United Kingdom. It operates through rental a...